A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

VAX-31’s safety, tolerability, and immunogenicity are being assessed in this trial on healthy infants. Vaxcyte anticipat ...

In a global first, Uganda’s Ministry of Health, the World Health Organization (WHO) and other partners today launched a first-ever clinical efficacy trial for a vaccine from Ebola from the Sudan ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

Although he remains puzzled by it all, Gates isn't too worried yet, even if outspoken vaccine skeptic Robert F. Kennedy Jr.

Meet the woman leading vaccine innovation in Senegal to fight Rift Valley fever and empower Africa’s next generation of ...

Spanish flu pandemic was caused by a particularly virulent strain of influenza virus. It infected 500 million people, caused ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide 27.01.2025 / 15:04 CET/CEST The issuer is solely responsible ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

Last Friday, HHS announced it will provide approximately $590 million to Moderna to accelerate the development of mRNA-based ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Vaxxas has announced that the CEPI, has approved the progression of a $7.2 million program to develop heat-stable, dried-formulation mRNA vaccines delivered using Vaxxas’ needle-free high-density ...